DE69509084D1 - Peptidische neurotensin-antagonisten - Google Patents
Peptidische neurotensin-antagonistenInfo
- Publication number
- DE69509084D1 DE69509084D1 DE69509084T DE69509084T DE69509084D1 DE 69509084 D1 DE69509084 D1 DE 69509084D1 DE 69509084 T DE69509084 T DE 69509084T DE 69509084 T DE69509084 T DE 69509084T DE 69509084 D1 DE69509084 D1 DE 69509084D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- compound
- radical
- date nov
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C27/00—Processes involving the simultaneous production of more than one class of oxygen-containing compounds
- C07C27/20—Processes involving the simultaneous production of more than one class of oxygen-containing compounds by oxo-reaction
- C07C27/22—Processes involving the simultaneous production of more than one class of oxygen-containing compounds by oxo-reaction with the use of catalysts which are specific for this process
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/083—Neurotensin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/18—Kallidins; Bradykinins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9406167A FR2720066B1 (fr) | 1994-05-20 | 1994-05-20 | Peptides antagonistes de la neurotensine. |
PCT/FR1995/000643 WO1995032218A1 (fr) | 1994-05-20 | 1995-05-17 | Peptides antagonistes de la neurotensine |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69509084D1 true DE69509084D1 (de) | 1999-05-20 |
DE69509084T2 DE69509084T2 (de) | 1999-08-12 |
Family
ID=9463378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69509084T Expired - Fee Related DE69509084T2 (de) | 1994-05-20 | 1995-05-17 | Peptidische neurotensin-antagonisten |
Country Status (13)
Country | Link |
---|---|
US (1) | US5840682A (de) |
EP (1) | EP0759934B1 (de) |
JP (1) | JPH10500424A (de) |
AT (1) | ATE178905T1 (de) |
AU (1) | AU2619595A (de) |
DE (1) | DE69509084T2 (de) |
DK (1) | DK0759934T3 (de) |
ES (1) | ES2132671T3 (de) |
FR (1) | FR2720066B1 (de) |
GR (1) | GR3029950T3 (de) |
IL (1) | IL113767A (de) |
WO (1) | WO1995032218A1 (de) |
ZA (1) | ZA954026B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0968001B1 (de) * | 1997-02-03 | 2003-11-05 | Mallinckrodt Inc. | Verfahren zur detektion und lokalisation maligner meschlicher tumore des pankreas |
DE10226921A1 (de) * | 2002-06-17 | 2003-12-24 | Bayer Ag | Antibakterielle Amid-Makrozyklen |
DE10358824A1 (de) * | 2003-12-16 | 2005-07-21 | Bayer Healthcare Ag | Antibakterielle Makrozyklen mit substituiertem Biphenyl |
DE102005014245A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen V |
DE102005014247A1 (de) * | 2005-03-30 | 2006-10-05 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Makrozyklen VI |
DE102005032781A1 (de) * | 2005-07-14 | 2007-01-18 | Aicuris Gmbh & Co. Kg | Antibakterielle Amid-Markozyklen VII |
EP2374003B1 (de) | 2009-01-07 | 2015-03-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Verfahren zur behandlung, prognosebeurteilung und erkennung von brustkrebs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4439359A (en) * | 1982-07-02 | 1984-03-27 | Merck & Co., Inc. | Cyclic octapeptide analogs of neurotensin |
US5162497A (en) * | 1987-09-24 | 1992-11-10 | The Administrators Of The Tulane Educational Fund | Bradykinin analogs with non-peptide bond |
US5430047A (en) * | 1994-04-07 | 1995-07-04 | Warner-Lambert Company | Neurotensin antagonists |
FR2720065B1 (fr) * | 1994-05-20 | 1996-06-28 | Rhone Poulenc Rorer Sa | Métabolite de fermentation d'actinomycètes A 9738 intermédiaire pour la préparation d'antagonistes de la neurotensine. |
-
1994
- 1994-05-20 FR FR9406167A patent/FR2720066B1/fr not_active Expired - Lifetime
-
1995
- 1995-05-17 IL IL11376795A patent/IL113767A/xx active IP Right Grant
- 1995-05-17 DE DE69509084T patent/DE69509084T2/de not_active Expired - Fee Related
- 1995-05-17 JP JP7530094A patent/JPH10500424A/ja active Pending
- 1995-05-17 DK DK95920949T patent/DK0759934T3/da active
- 1995-05-17 ZA ZA954026A patent/ZA954026B/xx unknown
- 1995-05-17 WO PCT/FR1995/000643 patent/WO1995032218A1/fr active IP Right Grant
- 1995-05-17 AT AT95920949T patent/ATE178905T1/de not_active IP Right Cessation
- 1995-05-17 EP EP95920949A patent/EP0759934B1/de not_active Expired - Lifetime
- 1995-05-17 US US08/737,695 patent/US5840682A/en not_active Expired - Fee Related
- 1995-05-17 AU AU26195/95A patent/AU2619595A/en not_active Abandoned
- 1995-05-17 ES ES95920949T patent/ES2132671T3/es not_active Expired - Lifetime
-
1999
- 1999-04-15 GR GR980400478T patent/GR3029950T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH10500424A (ja) | 1998-01-13 |
DK0759934T3 (da) | 1999-08-02 |
EP0759934A1 (de) | 1997-03-05 |
US5840682A (en) | 1998-11-24 |
ES2132671T3 (es) | 1999-08-16 |
FR2720066A1 (fr) | 1995-11-24 |
AU2619595A (en) | 1995-12-18 |
FR2720066B1 (fr) | 1996-06-28 |
GR3029950T3 (en) | 1999-07-30 |
IL113767A0 (en) | 1995-08-31 |
WO1995032218A1 (fr) | 1995-11-30 |
ATE178905T1 (de) | 1999-04-15 |
DE69509084T2 (de) | 1999-08-12 |
EP0759934B1 (de) | 1999-04-14 |
ZA954026B (en) | 1996-03-06 |
IL113767A (en) | 1999-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9604341D0 (sv) | Hepta-peptide oxytocin analogue | |
FR2364948A1 (fr) | Systemes adhesifs comprenant un polyamide contenant une bisamino piperazine | |
JP2012512903A5 (de) | ||
HUP0204272A2 (hu) | Kortikotropin-felszabadító faktor antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE116638T1 (de) | N-substituierte lactame als cholecystokinin- antagonisten. | |
ATE64396T1 (de) | Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
ATE184022T1 (de) | Neuropeptide y antagoniste | |
RS51852B (sr) | Modifikovani peptidi kao terapeutski agensi | |
DK1326634T3 (da) | Vaccinepræparat der omfatter et antigen og et peptid med adjuvansegenskaber | |
HUP0102579A2 (hu) | Antiangiogén hatású peptid gyógyszervegyületek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
DE69509084D1 (de) | Peptidische neurotensin-antagonisten | |
ES8707547A1 (es) | Procedimiento para preparar un oligopeptidil-argininol u-homoargininol o derivado de estos | |
DE60335101D1 (de) | Antimikrobielles polypeptid und nutzung davon | |
DE69637535D1 (de) | Mittel auf basis radiomarkierter peptide zur ortsspezifischen verabreichung | |
ATE254121T1 (de) | Heterocyclische verbindungen als bradykinin antagonisten | |
MX9801987A (es) | Nuevos derivados de aminoacido, su obtencion y su uso. | |
WO2002066500A2 (de) | ANTAGONISTEN FÜR Α4β7-INTEGRIN | |
ES2141827T3 (es) | Peptidos que tienen actividad antagonista de endotelina, su preparacion y composiciones farmaceuticas de los mismos. | |
DE68923592T2 (de) | HIV Protease-Hemmer. | |
DE60109412D1 (en) | Therapeutische peptide | |
ES8605769A1 (es) | Un procedimiento para la preparacion de un peptido | |
DE69119409D1 (de) | Vasoaktive derivate des vasotocins | |
DE3571990D1 (en) | Reduced peptides, inhibitors of gastric secretion, preparation process and pharmaceutical compositions containing them | |
JPWO2019164987A5 (de) | ||
DE69715910D1 (de) | Pharmazeutische zusammensetzung enthaltend peptide für die inhibierung der immunoglobulin-rezeptor interaktion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |